Bioactive compounds from the genus broussonetia

Dongho Lee, A. Douglas Kinghorn

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The genus Broussonetia of the Moraceae (mulberry family) is of both ethnomedical and industrial interest. Of the approximately 30 species in this genus, only three have been subjected to previous phytochemical investigation, namely, B. kazinoki, B. papyrifera, and B. zeylanica. From over 100 compounds isolated from these species, the major secondary metabolites reported thus far are alkaloids of the pyrrolidine type and several types of flavonoids. Some of these compounds have exhibited various biological activities, such antioxidative, aromatase inhibitory, cytotoxic, glycosidase inhibitory, and platelet aggregation inhibitory effects. The biologically active constituents of the species in the genus Broussonetia are discussed in detail.

Original languageEnglish
Pages (from-to)3-33
Number of pages31
JournalStudies in Natural Products Chemistry
Volume28
Issue numberPART I
DOIs
Publication statusPublished - 2003 Dec 1
Externally publishedYes

Fingerprint

Broussonetia
Aromatase
Glycoside Hydrolases
Phytochemicals
Metabolites
Platelets
Bioactivity
Alkaloids
Flavonoids
Agglomeration
Moraceae
Morus
Platelet Aggregation
pyrrolidine

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery

Cite this

Bioactive compounds from the genus broussonetia. / Lee, Dongho; Kinghorn, A. Douglas.

In: Studies in Natural Products Chemistry, Vol. 28, No. PART I, 01.12.2003, p. 3-33.

Research output: Contribution to journalArticle

Lee, Dongho ; Kinghorn, A. Douglas. / Bioactive compounds from the genus broussonetia. In: Studies in Natural Products Chemistry. 2003 ; Vol. 28, No. PART I. pp. 3-33.
@article{868902116f3149c19014318d9ed46d6e,
title = "Bioactive compounds from the genus broussonetia",
abstract = "The genus Broussonetia of the Moraceae (mulberry family) is of both ethnomedical and industrial interest. Of the approximately 30 species in this genus, only three have been subjected to previous phytochemical investigation, namely, B. kazinoki, B. papyrifera, and B. zeylanica. From over 100 compounds isolated from these species, the major secondary metabolites reported thus far are alkaloids of the pyrrolidine type and several types of flavonoids. Some of these compounds have exhibited various biological activities, such antioxidative, aromatase inhibitory, cytotoxic, glycosidase inhibitory, and platelet aggregation inhibitory effects. The biologically active constituents of the species in the genus Broussonetia are discussed in detail.",
author = "Dongho Lee and Kinghorn, {A. Douglas}",
year = "2003",
month = "12",
day = "1",
doi = "10.1016/S1572-5995(03)80137-0",
language = "English",
volume = "28",
pages = "3--33",
journal = "Studies in Natural Products Chemistry",
issn = "1572-5995",
publisher = "Elsevier",
number = "PART I",

}

TY - JOUR

T1 - Bioactive compounds from the genus broussonetia

AU - Lee, Dongho

AU - Kinghorn, A. Douglas

PY - 2003/12/1

Y1 - 2003/12/1

N2 - The genus Broussonetia of the Moraceae (mulberry family) is of both ethnomedical and industrial interest. Of the approximately 30 species in this genus, only three have been subjected to previous phytochemical investigation, namely, B. kazinoki, B. papyrifera, and B. zeylanica. From over 100 compounds isolated from these species, the major secondary metabolites reported thus far are alkaloids of the pyrrolidine type and several types of flavonoids. Some of these compounds have exhibited various biological activities, such antioxidative, aromatase inhibitory, cytotoxic, glycosidase inhibitory, and platelet aggregation inhibitory effects. The biologically active constituents of the species in the genus Broussonetia are discussed in detail.

AB - The genus Broussonetia of the Moraceae (mulberry family) is of both ethnomedical and industrial interest. Of the approximately 30 species in this genus, only three have been subjected to previous phytochemical investigation, namely, B. kazinoki, B. papyrifera, and B. zeylanica. From over 100 compounds isolated from these species, the major secondary metabolites reported thus far are alkaloids of the pyrrolidine type and several types of flavonoids. Some of these compounds have exhibited various biological activities, such antioxidative, aromatase inhibitory, cytotoxic, glycosidase inhibitory, and platelet aggregation inhibitory effects. The biologically active constituents of the species in the genus Broussonetia are discussed in detail.

UR - http://www.scopus.com/inward/record.url?scp=70449472768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449472768&partnerID=8YFLogxK

U2 - 10.1016/S1572-5995(03)80137-0

DO - 10.1016/S1572-5995(03)80137-0

M3 - Article

AN - SCOPUS:70449472768

VL - 28

SP - 3

EP - 33

JO - Studies in Natural Products Chemistry

JF - Studies in Natural Products Chemistry

SN - 1572-5995

IS - PART I

ER -